News & Perspective

Jun 12, 2015

Jun 12, 2015

News Scan for Jun 12, 2015

MERS in Saudi Arabia
Meningitis B vaccine recommendation
Meningitis in Niger
Neglected diseases in Africa

Feb 25, 2015

Feb 25, 2015

News Scan for Feb 25, 2015

New MERS case, study
Measles surge in Europe
Group B mening vaccine

Feb 05, 2015

Feb 05, 2015

News Scan for Feb 05, 2015

More California, Illinois measles
MERS still not emergency
FDA chief stepping down
Low adult vaccine coverage

Nov 18, 2014

Nov 18, 2014

Flu Scan for Nov 18, 2014

Global flu activity
H5N8 outbreak in UK
New H5N1 death in Egypt
LAIV uptake in children

Feb 07, 2014

Feb 07, 2014

News Scan for Feb 07, 2014

MERS case in UAE
Canadian H5N1 gene analysis
N95 respirators and bacterial infections
2014 ACIP recommendations

Jan 19, 2012

Jan 19, 2012

Review renews questions about oseltamivir benefits

(CIDRAP News) – A lengthy new analysis of unpublished clinical trial data is renewing questions about the effectiveness of the influenza drug oseltamivir (Tamiflu), saying that although the drug shortens flu symptoms by about a day, there is no evidence that it reduces hospital admissions.

Apr 26, 2010

Apr 26, 2010

H1N1 LESSONS LEARNED Vaccine production foiled, confirmed experts' predictions

Second in a series marking the 1-year anniversary of novel H1N1 pandemic influenza. The first, on the virus itself, appeared Apr 23.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»